BKHABlack Hawk Acquisition Corp同业对比
Black Hawk Acquisition Corp 与Biological Products, (No Diagnostic Substances)的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Biological Products, (No Diagnostic Substances))| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BKHA本股 | $49M#8 | — | — | — | — | -30.6%#10 | — | — | — | — | 126.3%#2 | 104.1%#1 |
| INMB | $65M#1 | — | 3.2x#7 | 1298.9x#7 | 257.1%#1 | -9.5%#5 | -94766.0%#8 | -225.9%#6 | -607.3%#2 | — | 18.8%#4 | — |
| LONA | $65M#2 | — | 1.9x#5 | — | — | -9.3%#4 | — | -315.5%#9 | — | — | 79.6%#3 | — |
| EXOZ | $62M#3 | — | 17.0x#8 | 887.5x#6 | — | -56.3%#13 | -13867.0%#6 | -250.6%#8 | — | — | -44.1%#7 | — |
| INKT | $59M#4 | — | — | — | — | -15.9%#8 | — | — | — | — | -19.0%#5 | — |
| IMA | $58M#5 | — | 0.4x#2 | 72.6x#3 | -77.1%#7 | -24.0%#9 | -6056.4%#4 | -31.9%#1 | — | — | -39.7%#6 | — |
| BKHAU | $53M#6 | — | — | — | — | -30.6%#10 | — | — | — | — | 133.8%#1 | 96.2%#2 |
| TVGN | $50M#7 | — | — | — | — | -91.4%#14 | — | — | — | — | -81.7%#14 | — |
| TIL | $49M#9 | — | 0.5x#3 | — | -100.0%#8 | 3.7%#3 | — | -66.5%#2 | — | — | -66.5%#12 | — |
| SCLX | $46M#10 | — | — | 1.5x#1 | -46.5%#5 | -413.8%#15 | -1143.7%#2 | — | — | 4#1 | -74.0%#13 | — |
| MGX | $42M#11 | — | 0.4x#1 | 1.7x#2 | -51.8%#6 | -12.6%#6 | -380.9%#1 | -78.1%#4 | — | — | -48.0%#8 | — |
| ATYR | $36M#12 | — | 0.7x#4 | 188.7x#5 | -19.1%#3 | -15.8%#7 | -40856.3%#7 | -151.9%#5 | -202.0%#1 | — | -65.0%#11 | — |
| ALGS | — | — | — | — | -39.5%#4 | 81.6%#1 | -4024.9%#3 | -75.9%#3 | — | — | -50.2%#9 | — |
| QNCX | $30M#13 | 0.2x#1 | — | — | — | -47.8%#12 | — | — | — | — | -90.7%#16 | — |
| CVM | $27M#14 | — | 2.5x#6 | 103.9x#4 | 65.5%#2 | 5.6%#2 | -9396.5%#5 | -231.9%#7 | — | — | -82.6%#15 | — |
| ESLA | $24M#15 | — | — | — | — | — | — | — | — | — | -50.9%#10 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-18。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议